DOTAZ Trademark

Trademark Overview

On Friday, October 25, 2013, a trademark application was filed for DOTAZ with the United States Patent and Trademark Office. The USPTO has given the DOTAZ trademark a serial number of 86101871. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 15, 2023. This trademark is owned by Glaxo Group Limited. The DOTAZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
dotaz

General Information

Serial Number86101871
Word MarkDOTAZ
Filing DateFriday, October 25, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 15, 2023
Registration Number5211485
Registration DateTuesday, May 30, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 1, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe English translation of the word "DOTAZ" in the mark is "query".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 15, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, December 15, 2023CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 30, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 30, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, February 24, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, February 24, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, August 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2016SOU EXTENSION 4 GRANTED
Thursday, July 28, 2016SOU EXTENSION 4 FILED
Thursday, July 28, 2016SOU TEAS EXTENSION RECEIVED
Friday, February 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2016SOU EXTENSION 3 GRANTED
Thursday, February 11, 2016SOU EXTENSION 3 FILED
Thursday, February 11, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 27, 2015SOU EXTENSION 2 GRANTED
Tuesday, June 30, 2015SOU EXTENSION 2 FILED
Friday, July 24, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 30, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 15, 2015SOU EXTENSION 1 GRANTED
Thursday, January 15, 2015SOU EXTENSION 1 FILED
Thursday, January 15, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, August 26, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 1, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 1, 2014PUBLISHED FOR OPPOSITION
Wednesday, June 11, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 28, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 23, 2014ASSIGNED TO LIE
Monday, May 12, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 12, 2014EXAMINER'S AMENDMENT ENTERED
Monday, May 12, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 12, 2014EXAMINERS AMENDMENT E-MAILED
Monday, May 12, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 18, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2014NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2014NON-FINAL ACTION WRITTEN
Tuesday, February 11, 2014ASSIGNED TO EXAMINER
Friday, November 1, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 29, 2013NEW APPLICATION ENTERED

Related Keywords

dotaz pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological